DOWNERS GROVE, Ill., Nov. 3, 2023 /PRNewswire/ — Dover (NYSE: DOV) today announced that its Board of Directors has elected Marc A. Howze as a new independent director effective immediately. Mr. Howze’s appointment increases the size of the Board to 11 directors, 10 of whom are independent directors. Mr. Howze will serve on the Board’s… Continue reading Dover Board Elects Marc A. Howze as New Independent Director
Category: Newswire
Ricinoleic Acid Market size to grow by USD 103.27 million from 2023 to 2028, Arvalli Castor Derivatives Pvt. Ltd, Adani Wilmar Ltd., Akshay Chemicals, and more among key companies – Technavio
NEW YORK, Nov. 3, 2023 /PRNewswire/ — The ricinoleic acid market is expected to grow by USD 103.27 million from 2023 to 2028. In addition, the growth momentum of the market will progress at a CAGR of 4.59% during the forecast period, according to Technavio. Growing demand from major end-users is notably driving the ricinoleic acid market. However, factors… Continue reading Ricinoleic Acid Market size to grow by USD 103.27 million from 2023 to 2028, Arvalli Castor Derivatives Pvt. Ltd, Adani Wilmar Ltd., Akshay Chemicals, and more among key companies – Technavio
FARFETCH SHAREHOLDER ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Farfetch To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Farfetch between March 9, 2023 and August 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/FTCH. There is no cost or obligation to you. NEW… Continue reading FARFETCH SHAREHOLDER ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Farfetch To Contact Him Directly To Discuss Their Options
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tigo Energy, Inc. – TYGO
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Tigo Energy, Inc. (“Tigo” or the “Company”) (NASDAQ: TYGO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Tigo and certain of its officers and/or directors have engaged in securities fraud… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tigo Energy, Inc. – TYGO
Maiello Brungo & Maiello, LLP Ranked by Best Law Firms® in 2024
MBM RANKED TOP TIER IN PITTSBURGH FOR REAL ESTATE LAWTIER 2: CONSTRUCTION LAW, EMPLOYMENT LAW – MANAGEMENT, LITIGATION -CONSTRUCTION PITTSBURGH, Nov. 3, 2023 /PRNewswire/ — Maiello Brungo & Maiello, LLP (MBM), has been recognized in the 2024 edition of Best Law Firms®, ranked by Best Lawyers®, regionally in four practice areas. The 2024 Best Law Firms® are… Continue reading Maiello Brungo & Maiello, LLP Ranked by Best Law Firms® in 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether SolarEdge and certain of its officers and/or directors have engaged in securities fraud or… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WALTHAM, Mass., Nov. 3, 2023 /PRNewswire/ — Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on November 1, 2023 the Company granted inducement awards to purchase up to 169,600 shares of common stock to ten new employees under the Company’s 2023 Inducement Plan. The stock options… Continue reading Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Deckers Releases its FY23 Creating Change Report
GOLETA, Calif., Nov. 3, 2023 /PRNewswire/ — Deckers Brands (NYSE:DECK), a global leader in designing, marketing, and distributing innovative footwear, apparel and accessories, today released its Fiscal Year 2023 Corporate Responsibility and Sustainability Report, Creating Change. Deckers’ FY23 Creating Change report builds on the progress made against its Sustainable Development Goals related to materials, waste, water,… Continue reading Deckers Releases its FY23 Creating Change Report
Movano Inc. to Report Third Quarter 2023 Financial Results Tuesday, November 14, 2023
PLEASANTON, Calif., Nov. 3, 2023 /PRNewswire/ — Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it will report third quarter 2023 financial and operating results on Tuesday, November 14, 2023. Management will host a conference call and live… Continue reading Movano Inc. to Report Third Quarter 2023 Financial Results Tuesday, November 14, 2023
Gravitas Education Updates Record Date of Special Cash Dividend
BEIJING, Nov. 3, 2023 /PRNewswire/ — Gravitas Education Holdings, Inc. (the “Company”) (NYSE: GEHI), a leading early childhood education service provider in China, today announced that, further to its announcement regarding the payment of a special dividend dated September 21, 2023, the Company expects that the special dividend will be paid on or before the 21st… Continue reading Gravitas Education Updates Record Date of Special Cash Dividend